Last updated 2026-08-22
- Raised $80M Series C led by NVIDIA, Jul 2024
- Raised $20M Series B led by Pfizer, Sep 2022
Total raised
$100.0M
Last: Undisclosed Round 2024-07
Stage
Series C
Founded
2016
Headcount
143
HQ
-, Israel
Sector
Healthcare
About
CytoReason is a technology company developing a computational model of the human body that simulates human disease on a cellular level, minimizes the need for animal trials, and makes human trials more focused and accurate.
With CytoReason's proprietary database and AI-led platform, pharmaceutical and biotechnology companies can make data-driven decisions quickly and cost effectively. To date, five of the world’s top ten pharma companies use CytoReason’s technology to identify new opportunities, shorten trial phases, reduce development costs, and increase the likelihood of drug approval.
Funding history · 2 rounds · $100.0M total
2 events/rounds · $100.0M Total Funding: $100.0M in Private Equity
Jul 2024
Sep 2022
★ Pfizer
Headcount over time
143 employees (2026-09) · 1 point
Offices
-, Israel · HQ / main office
Q&A
- What is CytoReason's primary focus?
- CytoReason is a technology company that develops a computational model of the human body to simulate human disease at a cellular level, aiming to reduce the need for animal trials and enhance the focus and accuracy of human trials.
- Which major pharmaceutical companies utilize CytoReason's technology?
- Five of the world’s top ten pharmaceutical companies use CytoReason’s technology for data-driven decisions in drug development.
- Has CytoReason expanded its collaboration with Sanofi recently?
- Yes, in January 2026, CytoReason announced the expansion of its collaboration with Sanofi for the third time to advance AI-driven drug discovery.
- What new AI agent did CytoReason unveil in January 2026?
- In January 2026, CytoReason unveiled LINA, an AI agent accelerated by NVIDIA for pharma R&D, built on computational disease models.
- What is the current employee count for CytoReason?
- CytoReason currently has 51–200 employees.
- When was CytoReason founded?
- CytoReason was founded in September 2016.
Team · 10
David Harel
Founder · Co-Founder & CEO
Elina Starosvetsky
Founder · Co-Founder & Chief Operating Officer
Renaud Gaujoux
Founder · Co-founder & Data Science Architect
Yuval Kalugny
Founder · Co-Founder & VP
Ksenya Kveler
Founder · Co-Founder
Prof. Yehuda Chowers
Chief Medical Officer
Haniel Ilouz
Chief R&D Officer
Nicole van Poppel
Chief Business Officer
Sectors & technology
Primary sector
Healthcare
Technologies
Target customers
Business model
B2B
Highlights
Verified
Tags
clinical-trialslaboratoriesartificial-intelligencehealthcare-providerspatent-pendingdrug-discoveryclinical-dataclinicsmedical-technologiesdata-analyticsdigital-healthcarebig-datapharma-companiescancermachine-learningbiotechnologybiopharmaceuticalimmunotherapyimmunologybioinformaticsmhealthautoimmune-diseasesmolecular-biologydecision-supportnatural-language-processingcells
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cytoreason.com |
|---|---|
| linkedin.com/company/12901361 | |
| YouTube | youtube.com/channel/UC7ys04qK-C1M83XTV3NbI6g |
Identifiers & details
| Founded | 2016-9 |
|---|---|
| Employees (exact) | 143 |
Radar intelligence
Publications (Crossref)
| Works | 6 |
|---|
GitHub
| Top repos | stress-load-testing-framework, langfuse, internal-apps-front, nf-amazon, streamlit-cyto |
|---|
Web history (Wayback)
| Domain | cytoreason.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515522134 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-09-12 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 5 — charge (3), people (2) |
| Registered address | דרך בגין 132 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-31 | רישום שעבוד |
| 2026-06-17 | עדכון דירקטורים-הוספת דירקטור |
| 2026-08-06 | רישום שעבוד |
| 2026-08-05 | עדכון דירקטורים-הסרת דירקטור |
| 2025-09-01 | סילוק שעבוד |